HUNTSMAN CORP (HUN) Fundamental Analysis & Valuation

NYSE:HUN • US4470111075

11.505 USD
+0.07 (+0.57%)
Last: Mar 9, 2026, 10:43 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This HUN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall HUN gets a fundamental rating of 2 out of 10. We evaluated HUN against 83 industry peers in the Chemicals industry. HUN may be in some trouble as it scores bad on both profitability and health. HUN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. HUN Profitability Analysis

1.1 Basic Checks

  • In the past year HUN has reported negative net income.
  • In the past year HUN had a positive cash flow from operations.
  • In multiple years HUN reported negative net income over the last 5 years.
  • Each year in the past 5 years HUN had a positive operating cash flow.
HUN Yearly Net Income VS EBIT VS OCF VS FCFHUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • With a Return On Assets value of -4.05%, HUN is not doing good in the industry: 68.67% of the companies in the same industry are doing better.
  • The Return On Equity of HUN (-10.41%) is worse than 66.27% of its industry peers.
Industry RankSector Rank
ROA -4.05%
ROE -10.41%
ROIC N/A
ROA(3y)-1.77%
ROA(5y)2.28%
ROE(3y)-4.58%
ROE(5y)4.6%
ROIC(3y)N/A
ROIC(5y)N/A
HUN Yearly ROA, ROE, ROICHUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • HUN has a Gross Margin of 13.21%. This is in the lower half of the industry: HUN underperforms 77.11% of its industry peers.
  • In the last couple of years the Gross Margin of HUN has declined.
  • The Profit Margin and Operating Margin are not available for HUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.81%
GM growth 5Y-6.28%
HUN Yearly Profit, Operating, Gross MarginsHUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. HUN Health Analysis

2.1 Basic Checks

  • HUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • HUN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, HUN has less shares outstanding
  • Compared to 1 year ago, HUN has a worse debt to assets ratio.
HUN Yearly Shares OutstandingHUN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
HUN Yearly Total Debt VS Total AssetsHUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • Based on the Altman-Z score of 1.52, we must say that HUN is in the distress zone and has some risk of bankruptcy.
  • HUN has a worse Altman-Z score (1.52) than 63.86% of its industry peers.
  • The Debt to FCF ratio of HUN is 17.34, which is on the high side as it means it would take HUN, 17.34 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of HUN (17.34) is comparable to the rest of the industry.
  • HUN has a Debt/Equity ratio of 0.61. This is a neutral value indicating HUN is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.61, HUN perfoms like the industry average, outperforming 57.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 17.34
Altman-Z 1.52
ROIC/WACCN/A
WACC9.75%
HUN Yearly LT Debt VS Equity VS FCFHUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • HUN has a Current Ratio of 1.30. This is a normal value and indicates that HUN is financially healthy and should not expect problems in meeting its short term obligations.
  • HUN has a worse Current ratio (1.30) than 80.72% of its industry peers.
  • HUN has a Quick Ratio of 1.30. This is a bad value and indicates that HUN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HUN has a worse Quick ratio (0.78) than 77.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.78
HUN Yearly Current Assets VS Current LiabilitesHUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. HUN Growth Analysis

3.1 Past

  • The earnings per share for HUN have decreased strongly by -914.29% in the last year.
  • The Revenue has decreased by -5.85% in the past year.
  • HUN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.14% yearly.
EPS 1Y (TTM)-914.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-48%
Revenue 1Y (TTM)-5.85%
Revenue growth 3Y-10.86%
Revenue growth 5Y-1.14%
Sales Q2Q%-6.68%

3.2 Future

  • The Earnings Per Share is expected to grow by 39.57% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 3.98% on average over the next years.
EPS Next Y36.37%
EPS Next 2Y42.57%
EPS Next 3Y39.57%
EPS Next 5YN/A
Revenue Next Year2.41%
Revenue Next 2Y3.97%
Revenue Next 3Y3.98%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HUN Yearly Revenue VS EstimatesHUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
HUN Yearly EPS VS EstimatesHUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

2

4. HUN Valuation Analysis

4.1 Price/Earnings Ratio

  • HUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year HUN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HUN Price Earnings VS Forward Price EarningsHUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HUN is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of HUN indicates a somewhat cheap valuation: HUN is cheaper than 77.11% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.26
EV/EBITDA 13.43
HUN Per share dataHUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • A more expensive valuation may be justified as HUN's earnings are expected to grow with 39.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.57%
EPS Next 3Y39.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. HUN Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.79%, HUN has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.08, HUN pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, HUN pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.79%

5.2 History

  • The dividend of HUN has a limited annual growth rate of 5.48%.
  • HUN has paid a dividend for at least 10 years, which is a reliable track record.
  • HUN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.48%
Div Incr Years4
Div Non Decr Years17
HUN Yearly Dividends per shareHUN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • The earnings of HUN are negative and hence is the payout ratio. HUN will probably not be able to sustain this dividend level.
  • HUN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-51.41%
EPS Next 2Y42.57%
EPS Next 3Y39.57%
HUN Yearly Income VS Free CF VS DividendHUN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M 1B

More info and screens

Find the best dividend stocksShow peers with best dividend

HUN Fundamentals: All Metrics, Ratios and Statistics

HUNTSMAN CORP

NYSE:HUN (3/9/2026, 10:43:08 AM)

11.505

+0.07 (+0.57%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-17
Earnings (Next)04-29
Inst Owners92.03%
Inst Owner Change-6.28%
Ins Owners5.49%
Ins Owner Change7.05%
Market Cap2.00B
Revenue(TTM)5.68B
Net Income(TTM)-284.00M
Analysts53.33
Price Target13.02 (13.17%)
Short Float %16.33%
Short Ratio4.71
Dividend
Industry RankSector Rank
Dividend Yield 2.79%
Yearly Dividend0.85
Dividend Growth(5Y)5.48%
DP-51.41%
Div Incr Years4
Div Non Decr Years17
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)34.48%
Min EPS beat(2)-11.62%
Max EPS beat(2)80.59%
EPS beat(4)1
Avg EPS beat(4)0.9%
Min EPS beat(4)-64.52%
Max EPS beat(4)80.59%
EPS beat(8)2
Avg EPS beat(8)-18.27%
EPS beat(12)3
Avg EPS beat(12)-16.12%
EPS beat(16)5
Avg EPS beat(16)-14.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)0%
Revenue beat(4)0
Avg Revenue beat(4)-2.61%
Min Revenue beat(4)-6.25%
Max Revenue beat(4)0%
Revenue beat(8)0
Avg Revenue beat(8)-2.11%
Revenue beat(12)1
Avg Revenue beat(12)-2.37%
Revenue beat(16)2
Avg Revenue beat(16)-2.32%
PT rev (1m)18.78%
PT rev (3m)27.69%
EPS NQ rev (1m)-45.16%
EPS NQ rev (3m)-55.37%
EPS NY rev (1m)-68.34%
EPS NY rev (3m)-100.24%
Revenue NQ rev (1m)-2.09%
Revenue NQ rev (3m)-2.5%
Revenue NY rev (1m)-0.88%
Revenue NY rev (3m)-1.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF 17.26
P/OCF 6.93
P/B 0.73
P/tB 1.12
EV/EBITDA 13.43
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)0.67
FCFY5.79%
OCF(TTM)1.66
OCFY14.44%
SpS32.66
BVpS15.67
TBVpS10.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.05%
ROE -10.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.21%
FCFM 2.04%
ROA(3y)-1.77%
ROA(5y)2.28%
ROE(3y)-4.58%
ROE(5y)4.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.81%
GM growth 5Y-6.28%
F-Score3
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 17.34
Debt/EBITDA 6.23
Cap/Depr 60.28%
Cap/Sales 3.04%
Interest Coverage N/A
Cash Conversion 108.65%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.78
Altman-Z 1.52
F-Score3
WACC9.75%
ROIC/WACCN/A
Cap/Depr(3y)68.89%
Cap/Depr(5y)83.8%
Cap/Sales(3y)3.29%
Cap/Sales(5y)3.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-914.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-48%
EPS Next Y36.37%
EPS Next 2Y42.57%
EPS Next 3Y39.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.85%
Revenue growth 3Y-10.86%
Revenue growth 5Y-1.14%
Sales Q2Q%-6.68%
Revenue Next Year2.41%
Revenue Next 2Y3.97%
Revenue Next 3Y3.98%
Revenue Next 5YN/A
EBIT growth 1Y-128.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3146.9%
EBIT Next 3Y268.04%
EBIT Next 5YN/A
FCF growth 1Y46.84%
FCF growth 3Y-43.47%
FCF growth 5Y96.1%
OCF growth 1Y9.89%
OCF growth 3Y-31.87%
OCF growth 5Y2.7%

HUNTSMAN CORP / HUN FAQ

What is the fundamental rating for HUN stock?

ChartMill assigns a fundamental rating of 2 / 10 to HUN.


Can you provide the valuation status for HUNTSMAN CORP?

ChartMill assigns a valuation rating of 2 / 10 to HUNTSMAN CORP (HUN). This can be considered as Overvalued.


How profitable is HUNTSMAN CORP (HUN) stock?

HUNTSMAN CORP (HUN) has a profitability rating of 1 / 10.


How financially healthy is HUNTSMAN CORP?

The financial health rating of HUNTSMAN CORP (HUN) is 2 / 10.


What is the earnings growth outlook for HUNTSMAN CORP?

The Earnings per Share (EPS) of HUNTSMAN CORP (HUN) is expected to grow by 36.37% in the next year.